Vireo Growth Inc. balance sheet VREOF

Annual Quarterly

As of Jun 30, 2026, Vireo Growth Inc. had total assets of $1.3 billion and total liabilities of $831.2 million. Total assets were up 93.2% from a year earlier. Stockholders' equity was $442.5 million. It held $115.8 million in cash and investments against $163.4 million of total debt, net debt of $47.6 million. The current ratio, current assets divided by current liabilities, was 1.01.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Assets
Cash	103 +4.0%	122 +41.9%	102 +11.6%	97 +1234.5%	99 +782.8%	86 +584.4%	92 +473.8%	7 -45.2%
Short-term investments	1 -0.4%	1	1	1	1	—	—	—
Long-term investments	12 -10.7%	6	6	6	13	—	—	—
Cash and investments	116 +2.3%	129 +50.0%	109 +19.2%	104 +1330.9%	113 +908.4%	86 +584.4%	92 +473.8%	7 -45.2%
Receivables	—	14 +481.6%	13 +342.5%	11 +292.9%	9 +304.5%	2 -12.0%	3 +27.2%	3 -49.9%
Inventory	149 +137.0%	76 +226.0%	60 +176.9%	54 +171.6%	63 +213.7%	23 +20.6%	22 +12.3%	20 +4.1%
Total current assets	394 +26.1%	258 +13.1%	305 +32.4%	308 +113.9%	313 +110.4%	228 +55.2%	230 +54.8%	144 +6.6%
Property and equipment, net	281 +153.7%	232 +607.5%	218 +573.1%	121 +297.4%	111 +321.4%	33 +39.5%	32 +38.7%	31 +28.1%
Goodwill	161 +121.8%	124	88	97	73	—	0	—
Total assets	1,274 +93.2%	929 +235.3%	817 +193.0%	679 +250.2%	659 +238.7%	277 +45.1%	279 +52.2%	194 +12.9%
Liabilities and equity
Total current liabilities	391 +60.4%	216 +56.8%	192 +41.5%	235 +82.4%	244 +30.4%	138 -25.3%	135 -24.5%	129 -22.2%
Total liabilities	831 +112.7%	635 +180.1%	510 +128.3%	433 +111.2%	391 +79.9%	227 +6.2%	223 +12.0%	205 +11.0%
Stockholders' equity	442 +64.7%	294 +482.4%	307 +453.9%	246 +2338.5%	269 +1290.7%	50 +323.7%	56 +445.9%	-11 +14.4%
Debt
Lease liabilities	163	—	—	—	—	—	—	—
Total debt	163	—	—	—	—	—	—	—
Net cash	-48	—	—	—	—	—	—	—
Ratios
Current ratio	1.01x	1.20x	1.59x	1.31x	1.28x	1.66x	1.70x	1.12x
Debt to equity	0.37x	—	—	—	—	—	—	—
Debt to EBITDA	6.34x	—	—	—	—	—	—	—
Return on equity	-15.17%	-27.85%	-22.16%	-25.76%	-15.65%	-55.04%	-50.46%	—
Return on assets	-5.27%	-8.82%	-8.34%	-9.34%	-6.37%	-10.03%	-10.04%	-8.71%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: VREOF (OTC)
Fiscal year ends: December 31
Incorporated in: British Columbia, Canada
Headquarters: Minneapolis, MN
SEC filer status: , Emerging growth company
SEC CIK: 1771706
Former names: Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.